Outcome of Board Meeting held today to consider and approve Audited Standalone Financial Results and Dividend
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kronox Lab Sciences Ltd reported audited standalone financial results for FY2025-26 ending March 31, 2026. Revenue from operations grew marginally to Rs 10,122 Lacs from Rs 10,019.4 Lacs in the previous year. Profit after tax increased to Rs 2,766 Lacs versus Rs 2,546.7 Lacs, representing approximately 8.6% PAT growth. EPS improved to Rs 7.51 from Rs 6.91. The Board declared a final dividend of 5% (Rs 0.50 per equity share of Rs 10 face value). The statutory auditors issued an unmodified opinion, confirming clean audit findings. The company operates in a single reportable segment manufacturing High Purity Specialty Fine Chemicals.
Solid financial performance with modest revenue growth and improved profitability. Clean audit opinion and dividend declaration are positive signals for shareholders. The stock may see neutral to slightly positive reaction given the steady but not exceptional growth.